Cholesteryl ester transfer protein TaqIB polymorphism in the cholesterol and recurrent events study.
作者信息
Marian Ali J
出版信息
Curr Atheroscler Rep. 2005 May;7(3):178-9.
PMID:15811250
Abstract
摘要
相似文献
1
Cholesteryl ester transfer protein TaqIB polymorphism in the cholesterol and recurrent events study.
Curr Atheroscler Rep. 2005 May;7(3):178-9.
2
The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy.
J Am Coll Cardiol. 2004 Mar 3;43(5):854-7. doi: 10.1016/j.jacc.2003.08.056.
3
Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatin.
J Intern Med. 2006 Aug;260(2):151-9. doi: 10.1111/j.1365-2796.2006.01674.x.
4
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
Circulation. 2005 Jan 25;111(3):278-87. doi: 10.1161/01.CIR.0000153341.46271.40. Epub 2005 Jan 17.
5
The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group.
N Engl J Med. 1998 Jan 8;338(2):86-93. doi: 10.1056/NEJM199801083380203.
6
Polymorphism of the cholesteryl ester transfer protein gene.
N Engl J Med. 1998 May 28;338(22):1625-6.
7
Polymorphism of the cholesteryl ester transfer protein gene.
N Engl J Med. 1998 May 28;338(22):1624-5; author reply 1625-6. doi: 10.1056/NEJM199805283382213.
8
In search of perverse polymorphisms.
N Engl J Med. 1998 Jan 8;338(2):122-4. doi: 10.1056/NEJM199801083380210.
9
CETP genotype predicts increased mortality in statin-treated men with proven cardiovascular disease: an adverse pharmacogenetic interaction.
Eur Heart J. 2008 Nov;29(22):2792-9. doi: 10.1093/eurheartj/ehn465. Epub 2008 Oct 28.
10
Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS).
Eur J Clin Invest. 2004 Jan;34(1):21-8. doi: 10.1111/j.1365-2362.2004.01281.x.
Zotero 插件